|
|
|
GAL1 receptor
|
|
|
Hs |
Antagonist |
Antagonist |
9.4 – 10.6 |
pKi |
- |
2,5,7 |
|
⤷ |
pKi
9.4 – 10.6
(Ki 4x10-10 – 2.7x10-11 M)
[2,5,7]
|
GAL2 receptor
|
|
|
Am |
Antagonist |
Antagonist |
9.0 |
pKi |
- |
2 |
|
⤷ |
pKi
9.0
(Ki 1.07x10-9 M)
[2]
|
GAL2 receptor
|
|
|
Mm |
Antagonist |
Antagonist |
8.9 |
pKi |
- |
8 |
|
⤷ |
pKi
8.9
(Ki 1.4x10-9 M)
[8]
|
GAL1 receptor
|
|
|
Rn |
Antagonist |
Antagonist |
8.0 – 9.2 |
pKi |
- |
9-11,13 |
|
⤷ |
pKi
8.0 – 9.2
(Ki 1x10-8 – 6.5x10-10 M)
[9-11,13]
|
GAL1 receptor
|
|
|
Mm |
Antagonist |
Antagonist |
8.2 – 8.6 |
pKi |
- |
8,15 |
|
⤷ |
pKi
8.2 – 8.6
(Ki 6.3x10-9 – 2.24x10-9 M)
[8,15]
|
GAL2 receptor
|
|
|
Rn |
Antagonist |
Antagonist |
7.8 – 9.0 |
pKi |
- |
7-8,10-11,13-14 |
|
⤷ |
pKi
7.8 – 9.0
(Ki 1.57x10-8 – 1x10-9 M)
[7-8,10-11,13-14]
|
GAL3 receptor
|
|
|
Rn |
Antagonist |
Antagonist |
7.1 – 8.0 |
pKi |
- |
7,11,14 |
|
⤷ |
pKi
7.1 – 8.0
(Ki 8.5x10-8 – 1.05x10-8 M)
[7,11,14]
|
GAL3 receptor
|
|
|
Hs |
Antagonist |
Antagonist |
7.4 |
pKi |
- |
2,11 |
|
⤷ |
pKi
7.4
(Ki 3.981x10-8 M)
[2,11]
|
GAL2 receptor
|
|
|
Hs |
Antagonist |
Antagonist |
8.0 – 9.2 |
pEC50 |
- |
1-3 |
|
⤷ |
pEC50
8.0 – 9.2
(EC50 9.12x10-9 – 6.5x10-10 M)
[1-3]
|
GAL2 receptor
|
|
|
Rn |
Antagonist |
Antagonist |
6.5 |
pEC50 |
- |
10 |
|
⤷ |
pEC50
6.5
(EC50 3x10-7 M)
[10]
|
GAL1 receptor
|
|
|
Rn |
Antagonist |
Antagonist |
9.0 |
pIC50 |
- |
6,12 |
|
⤷ |
pIC50
9.0
(IC50 1x10-9 M)
[6,12]
|
GAL1 receptor
|
|
|
Hs |
Antagonist |
Antagonist |
8.8 – 8.8 |
pIC50 |
- |
3,12 |
|
⤷ |
pIC50
8.8 – 8.8
(IC50 1.5x10-9 – 1.46x10-9 M)
[3,12]
|
GAL2 receptor
|
|
|
Hs |
Antagonist |
Antagonist |
8.4 |
pIC50 |
- |
3 |
|
⤷ |
pIC50
8.4
(IC50 4.02x10-9 M)
[3]
|
GAL2 receptor
|
|
|
Rn |
Antagonist |
Antagonist |
7.6 – 8.3 |
pIC50 |
- |
4,6 |
|
⤷ |
pIC50
7.6 – 8.3
(IC50 2.8x10-8 – 4.8x10-9 M)
[4,6]
|
|